New England Research & Management, Inc. - Q3 2023 holdings

$175 Thousand is the total value of New England Research & Management, Inc.'s 149 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 100.0% .

 Value Shares↓ Weighting
GMRE ExitGlobal Medical REIT Inc.cs$0-10,142
-100.0%
-0.05%
INMD ExitInMode Ltd.cs$0-5,825
-100.0%
-0.13%
RVNC ExitRevance Therapeuticscs$0-8,875
-100.0%
-0.13%
OVV ExitOvintiv Inc.cs$0-5,950
-100.0%
-0.13%
TSEM ExitTower Semiconductorcs$0-6,150
-100.0%
-0.13%
MPC ExitMarathon Petroleumcs$0-1,993
-100.0%
-0.14%
ADBE ExitAdobe Systemscs$0-575
-100.0%
-0.16%
FLR ExitFluorcs$0-11,950
-100.0%
-0.20%
MXL ExitMaxLinear, Inc.cs$0-11,374
-100.0%
-0.21%
GLW ExitCorningcs$0-10,525
-100.0%
-0.21%
WPC ExitW.P. Carey & Co.cs$0-5,537
-100.0%
-0.22%
CCI ExitCrown Castle Inc.cs$0-3,420
-100.0%
-0.23%
ZBRA ExitZebra Technologiescs$0-1,350
-100.0%
-0.23%
WAT ExitWaterscs$0-1,585
-100.0%
-0.24%
TXT ExitTextroncs$0-6,700
-100.0%
-0.26%
AWK ExitAmerican Water Workscs$0-3,400
-100.0%
-0.28%
TTWO ExitTake Two Interactive Softwarecs$0-3,575
-100.0%
-0.30%
APA ExitAPA Corporationcs$0-15,525
-100.0%
-0.31%
ExitLinde PLCcs$0-1,450
-100.0%
-0.32%
REGN ExitRegeneron Pharmaceuticalscs$0-940
-100.0%
-0.39%
VLO ExitValerocs$0-6,975
-100.0%
-0.47%
CB ExitChubbcs$0-6,930
-100.0%
-0.77%
PXD ExitPioneer Natural Resourcescs$0-6,525
-100.0%
-0.78%
LYB ExitLyondellBasell Industriescs$0-15,325
-100.0%
-0.82%
PCAR ExitPaccarcs$0-18,075
-100.0%
-0.88%
EQT ExitEQT Corpcs$0-46,950
-100.0%
-1.12%
J ExitJacobs Solutions Inc.cs$0-26,725
-100.0%
-1.84%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-10-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Church and Dwight40Q3 20235.1%
Johnson & Johnson40Q3 20233.9%
Cisco Systems40Q3 20233.4%
Kimberly-Clark40Q3 20232.9%
Apple Computer40Q3 20233.4%
Exxon Mobil40Q3 20232.9%
Pfizer40Q3 20232.3%
Microsoft40Q3 20232.8%
CSX Corp40Q3 20232.2%
Merck40Q3 20231.9%

View New England Research & Management, Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-16
13F-HR2024-02-06
13F-HR2023-10-10
13F-HR2023-07-05
13F-HR2023-04-06
13F-HR2023-01-09
13F-HR2022-10-06
13F-HR2022-07-20
13F-HR2022-04-20
13F-HR2022-01-05

View New England Research & Management, Inc.'s complete filings history.

Compare quarters

Export New England Research & Management, Inc.'s holdings